Local Research

We are conducting a clinical study in adults between 65-80 years old, who are at risk of developing Alzheimer’s disease, to evaluate the efficacy of a new medication in preventing the development of Alzheimer’s disease.

You may be eligible if you answer yes to all the following questions:

• Do you have a Family History of Alzheimer’s disease?
• Do you worry you may develop Alzheimer’s disease in the future?
• Are you between the ages of 65-80?

The study is evaluating Remternetug, a drug that targets and clears amyloid plaques from the brain to help prevent and slow Alzheimer’s progression in at-risk individuals.